Novavax filed for authorization with Health Canada today for its protein-based COVID-19 vaccine. Stanley Erck, President & CEO, Novavax tells BNN Bloomberg that its vaccine can be mixed & matched with others and that it's scaling production globally.
Tuesday 1 February 2022
Novavax files for COVID-19 vaccine authorization with Health Canada
Novavax files for COVID-19 vaccine authorization with Health Canada:
Subscribe to:
Posts (Atom)